Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance
Drug Development Research · 2026-08 · 87 (5)
DOI: 10.1002/ddr.70335 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 19.06.2026. Verfasst von Rui Liao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, Chongqing, China. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Bacterial Vaccines, RNA, Messenger, mRNA Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
The relentless rise of antimicrobial resistance poses a critical threat to global health, urgently demanding the development of antibacterial vaccines. Messenger RNA (mRNA) technology, validated during the COVID‐19 pandemic, offers a powerful platform of fast development and flexibility. However, its application against bacterial pathogens remains an emerging frontier due to the structural complexity of bacterial antigens, challenges in achieving effective mucosal and cellular delivery, and the need to elicit balanced Th1/Th17‐dominated immune responses for durable protection. Progress in antigen design, mRNA engineering, and lipid nanoparticle (LNP) delivery has enabled early preclinical success against Mycobacterium tuberculosis , Pseudomonas aeruginosa , and Streptococcus pneumoniae . Yet, challenges such as complex antigen expression, mucosal targeting, and immune durability persist. This review provides a brief overview of recent advances in bacterial mRNA vaccine design, including antigen selection, mRNA engineering, and delivery platform optimization. Additionally, we summarize current preclinical progress across key bacterial pathogens and highlight emerging strategies that integrate AI‐guided antigen discovery, synthetic biology, and next‐generation delivery systems to accelerate clinical translation. Finally, we highlight the prospects of bacterial mRNA vaccines by integrating synthetic biology, AI‐driven antigen prediction, and advanced delivery systems. These cutting‐edge technologies hold the promise of overcoming existing barriers, ultimately establishing mRNA vaccines as a viable and powerful strategy to curb the tide of antibiotic‐resistant infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, Chongqing, China.
- National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, Chongqing, China.
- Department of Pediatrics, Ludwig-Maximilians University, Munich, Bavaria, Germany.
- Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Shan Guan
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Natural Science Foundation of Chongqing
Zitieren
APA
Liao, R., Luo, M., Yang, F., Xu, L., Zhang, J., Zhang, W., Guan, S., Zhang, Y., Luo, P., Cheng, P., Yang, J., Li, Y., & Wang, Q. (2026). Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance. Drug Development Research, 87(5). https://doi.org/10.1002/ddr.70335
Vancouver
Liao R, Luo M, Yang F, Xu L, Zhang J, Zhang W, et al. Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance. Drug Development Research. 2026;87(5). doi:10.1002/ddr.70335
BibTeX
@article{Liao2026,
author = {Liao, Rui and Luo, Mingxing and Yang, Fating and Xu, Lifeng and Zhang, Jingjing and Zhang, Weijun and Guan, Shan and Zhang, Yi and Luo, Ping and Cheng, Ping and Yang, Jing and Li, Yang and Wang, Qian},
title = {Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {5},
doi = {10.1002/ddr.70335}
}
EUVIMED